Thiomersal: implementation of the warning statement relating to sensitisation - Scientific guideline

HumanScientific guidelines

This document provides guidance on the wording of the summary of product characterisitics and the package leaflet for the use of thiomersal in medicinal products with regard to sensitisation.

A 2016 review of this guideline concluded that it remains up-to-date and relevant.

Keywords: Thiomersal, preservative, vaccines, immunoglobulins, antimicrobial, organomercuric, summary of product characteristics (SmPC), sensitisation

Current version

Share this page